The Daily Overview on MSN
Eli Lilly's surprise dividend story could be a 2026 must-own
Eli Lilly has quietly turned a blockbuster obesity and diabetes franchise into one of the market's most intriguing income ...
MarketBeat on MSN
Eli Lilly's new drug data sets up a high-stakes 2026
Since early August, the world’s most valuable pharmaceutical stock, Eli Lilly and Company (NYSE: LLY), has put on a stellar ...
But Eli Lilly's Zepbound is best in class. Zepbound caused greater average weight loss than Wegovy in a head-to-head study.
Eli Lilly And Co (NASDAQ: LLY) shares are trading down on Tuesday as investors weigh the competitive landscape in the pharmaceutical sector.
Alpha Wealth Funds, LLC, an investment management company, released its Q3 2025 letter for the “Insiders Fund”. A copy of the ...
Inquisitr on MSN
New Eli Lilly and Company commercial divides viewers over alleged pro-obesity message
Social media users can’t stop talking about a new Eli Lilly and Company commercial that some believe promotes obesity, while ...
Eli Lilly is considering all these risks and planning accordingly, and doing so years in advance. That's also why the ...
US Weekly on MSN
‘Southern Hospitality’ Star Grace Lilly Is Arrested for 2nd-Degree Harassment Amid Drug Violation
Southern Hospitality's Grace Lilly has been arrested for harassment — with police allegedly finding “happy pills” in her ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback